CHARLES SCHWAB INVESTMENT MANAGEMENT INC - RHYTHM PHARMACEUTICALS INC ownership

RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 123 filers reported holding RHYTHM PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 2.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of RHYTHM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$8,820,348
+52.6%
384,748
+9.8%
0.00%
+50.0%
Q2 2023$5,780,718
+42.1%
350,559
+53.7%
0.00%
+100.0%
Q1 2023$4,068,180
-39.2%
228,037
-0.8%
0.00%
-50.0%
Q4 2022$6,695,154
+33.8%
229,916
+12.6%
0.00%0.0%
Q3 2022$5,005,000
+598.0%
204,269
+18.3%
0.00%
Q2 2022$717,000
-79.1%
172,730
-42.1%
0.00%
-100.0%
Q1 2022$3,437,000
+19.1%
298,325
+3.2%
0.00%0.0%
Q4 2021$2,886,000
-17.0%
289,106
+8.5%
0.00%0.0%
Q3 2021$3,479,000
-33.6%
266,362
-0.5%
0.00%
-50.0%
Q2 2021$5,241,000
-2.3%
267,631
+6.1%
0.00%0.0%
Q1 2021$5,365,000
-13.6%
252,222
+20.8%
0.00%0.0%
Q4 2020$6,210,000
+39.3%
208,873
+1.5%
0.00%0.0%
Q3 2020$4,459,000
-4.8%
205,741
-2.1%
0.00%0.0%
Q2 2020$4,686,000
+64.2%
210,124
+12.1%
0.00%0.0%
Q1 2020$2,853,000
-32.3%
187,421
+2.1%
0.00%0.0%
Q4 2019$4,214,000
+48.7%
183,512
+39.9%
0.00%0.0%
Q3 2019$2,833,000
+0.3%
131,216
+2.2%
0.00%0.0%
Q2 2019$2,824,000
-5.9%
128,339
+17.3%
0.00%0.0%
Q1 2019$3,000,000
+6.8%
109,422
+4.7%
0.00%0.0%
Q4 2018$2,810,000
-8.9%
104,522
-1.2%
0.00%0.0%
Q3 2018$3,086,000
+107.4%
105,793
+122.3%
0.00%
+100.0%
Q2 2018$1,488,000
+134.3%
47,595
+49.2%
0.00%
Q1 2018$635,000
-29.8%
31,900
+2.6%
0.00%
-100.0%
Q4 2017$904,00031,0810.00%
Other shareholders
RHYTHM PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 909,258$11,875,0002.75%
RA Capital Management 4,871,067$63,616,0000.88%
NEA Management Company, LLC 4,912,306$64,155,0000.76%
Samsara BioCapital, LLC 300,293$3,922,0000.62%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,989,625$25,985,0000.51%
Baker Brothers Advisors 3,863,239$50,454,0000.22%
ACT CAPITAL MANAGEMENT, LLC 31,000$405,0000.21%
Rock Springs Capital Management LP 612,180$7,995,0000.17%
GILDER GAGNON HOWE & CO LLC 1,496,424$19,543,0000.10%
FEDERATED HERMES, INC. 3,011,053$39,324,0000.08%
View complete list of RHYTHM PHARMACEUTICALS INC shareholders